Dulaglutide and exenatide were not significantly associated with NAION (HR = 0.96 and 1.16, respectively)
Real-World Patient Experiences and Choosing the Right Medication What Clinical Guidelines Recommend Professional societies now position GLP-1 medications prominently in treatment algorithms
Defining what and how much to cover Greater alignment with national health technology assessment bodies (HTAs) could create more consensus among insurers as to which new innovations are included in cover, while balancing value, affordability and ethics
It is important to note, as with all drug side effects, that not all people will experience these
While many of the tests in this category have remained the same over time, Everlywell has discontinued its Heavy Metals Test
Gallbladder Disease: Trulicity may increase a persons risk of developing conditions like cholecystitis (gallbladder inflammation) and gallstones, which may require medical attention